LSC Webinars
-
Integrated Manufacturing To Mitigate CMC Risks, Simplify Commercial Supply
10/15/2025
Leveraging cross-functional coordination between sites, harmonized tech transfers, one quality system, and synchronized team activities can streamline regulatory submissions and deliver high-quality commercial outcomes.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
10/14/2025
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
Liquid Phase Peptide Synthesis: Regulatory, Analytical, And QC Perspectives
10/3/2025
Discover how Liquid Phase Peptide Synthesis (LPPS) uses traditional reactors to create more efficient and sustainable peptide manufacturing. Learn about key analytical and quality control considerations.
-
Supply Resiliency For Bioprocessing Amid Global Volatility
10/2/2025
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
-
Filtration Unfiltered: Technology To Meet New Bioprocessing Challenges
9/29/2025
Explore how filtration strategies are adapting to diverse molecule pipelines, regulations, and sustainability targets with insights into process intensification and the technologies shaping the future.
-
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions
9/25/2025
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
-
Not All Manufacturing Automation Is Created Equal
9/25/2025
Learn how outcome-based automation helps life sciences manufacturers reduce risk, improve performance, and drive measurable results—by aligning tools with business goals.
-
Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency
9/25/2025
Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.
-
Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months
9/17/2025
Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.
-
Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery
9/9/2025
Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.